Health
Convalescent plasma reduced death rate among COVID-19 patients, study signals – The Australian
COVID-19 patients who received transfusions of blood plasma rich with antibodies from recovered patients reduced their mortality rate by about 50 per cent, according to researchers running a large US study.
- By Amy Dockser Marcus
- The Wall Street Journal
- 7:29PM August 5, 2020
- Comments
COVID-19 patients who received transfusions of blood plasma rich with antibodies from recovered patients reduced their mortality rate by about 50 per cent, according to researchers running a large US study.
The researchers presented their data analysis over the weekend in a webinar for physicians interested in learning about so-called convalescent plasma, with data slides that w…
-
General14 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoBetty’s Burgers National Burger Day
-
General24 hours agoThree maps that show the scale of the NSW flood disaster
-
General14 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire